secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001193125-25-315047
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam repurchases $34.4M of 1.00% convertible notes due 2027 for ~$51.9M
--------------------------------------------------------------------------

- Repurchased $34.4M aggregate principal of 1.00% convertible senior notes due 2027 for total cash cost of approximately $51.9M, including accrued interest.
- Remaining outstanding principal after repurchases is $362.8M.
- Repurchase price is subject to adjustment based on daily VWAP over a measurement period starting December 11, 2025.
- Existing capped call transactions entered upon note issuance remain in effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312525315047/0001193125-25-315047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312525315047/d201569d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-315047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer